Eli Lilly to introduce authorized generic of its HumalogLilly's authorized generic version of Humalog will be available in U.S. pharmacies at a 50% lower list price. Camber launches generic LovazaCamber has expanded its portfolio with the introduction of generic Lovaza, indicated to lower triglycerides. Hikma launches generic Zytiga Hikma's generic Zytiga is indicated as a treatment for metastatic castration-resistant prostate cancer. Amring expands generic product launches Amring Pharmaceuticals' generic portfolio is expanding with several launches planned this year. Lupin launches generic Solodyn Minocycline hydrochloride ER tablets had a market value of roughly $76.8 million. Lupin gets FDA clearance for generic Medrol tablets Generic Medrol tablets had a market value of roughly $114.3 million for the year ended December 2018. Nexus Pharmaceuticals gets FDA nod for generic Compazine Nexus Pharmaceuticals' generic Compazine offers a treatment for severe nausea, vomiting and schizophrenia. Alembic gets FDA nod for 2 generics Alembic has received the FDA ok for generic Vigamox, and Tricore, which have a market value of $68 million, and $92 million, respectively, for the 12 months ending December 2018. Indivior launches authorized generic of its own Suboxone sublingual film Indivior is introducing an authorized generic of its own Suboxone, in anticipation of generic competition from Dr. Reddy's and Alvogen. Dr. Reddy's relaunches generic Suboxone sublingual film On the heels of a favorable U.S. Court of Appeals ruling, Dr. Reddy's is relaunching its generic Suboxone sublingual film First Previous 198 199 200 201 202 Next Last
